ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $30,552,000 | -12.5% | 408,504 | -26.3% | 0.41% | +51.3% |
Q2 2020 | $34,905,000 | -99.9% | 554,491 | -16.7% | 0.27% | +1.1% |
Q1 2020 | $27,122,507,000 | -10.3% | 665,583 | 0.0% | 0.27% | +31.7% |
Q4 2019 | $30,230,780,000 | +99134.4% | 665,583 | 0.0% | 0.20% | -4.7% |
Q3 2019 | $30,464,000 | -21.9% | 665,583 | 0.0% | 0.21% | -20.9% |
Q2 2019 | $39,023,000 | +30.8% | 665,583 | 0.0% | 0.27% | +27.0% |
Q1 2019 | $29,838,000 | – | 665,583 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |